MGAT2 has a pivotal role in lipid metabolism in the small intestine, and the inhibition of MGAT2 activity may be a promising strategy for the treatment of obesity and type 2 diabetes. The gene discussed is MGAT2; the disease is obesity due to melanocortin 4 receptor deficiency.